OvaScience, Inc. — Form D/A

OvaScience, Inc. of Cambridge, MA, a company, filed a Form D amendment with the SEC on 2012-08-14. The offering totals $4.9M, of which $4.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Richard A. AldrichDirectorCambridge, MA
Jeff A. CapelloDirectorCambridge, MA
Stephen A. KrausDirectorCambridge, MA
John A. SimonDirectorCambridge, MA
Jonathan A. TillyDirectorCambridge, MA
Christoph A. WestphalDirectorCambridge, MA
Christopher A. BleckExecutive OfficerCambridge, MA
Scott A. ChappelExecutive OfficerCambridge, MA
Matthew AngelRelated PersonBrisbane, CA
Christine PellizzariRelated PersonBrisbane, CA
Michelle DippDirectorBOSTON, MA
Michelle DippExecutive OfficerBOSTON, MA
Michael W RaabDirectorSouth San Francisco, CA
Ronit W SimantovDirectorSouth San Francisco, CA
Thomas W WoiwodeDirectorSouth San Francisco, CA
Geoffrey W NicholDirectorSouth San Francisco, CA
Thomas W DubenskyDirectorSouth San Francisco, CA
Thomas W DubenskyExecutive OfficerSouth San Francisco, CA
Christine W PellizzariDirectorSouth San Francisco, CA
Michael RaabRelated PersonBrisbane, CA
Stephen R BradyDirectorSeattle, WA
Stephen R BradyExecutive OfficerSeattle, WA
Harald A StockDirectorCambridge, MA
Alison A LawtonExecutive OfficerCambridge, MA
Christoph A WestphalDirectorCambridge, MA

Other filings by this issuer (8)

FiledFormOfferingSold
2026-06-23D$4.1M$4.1M
2026-04-03D$2.0M$2.0M
2022-05-11D$15.0M$15.0M
2013-03-28D$35.0M$35.0M
2012-08-03D/A$4.1M$4.1M
2012-07-20D/A$3.6M$3.6M
2012-07-05D$1.4M$1.4M
2012-04-09D$37.2M$37.2M

More